The seed capital will help UAB-founded TriAltus Bioscience commercialise its protein purification materials, which are already being used by research clients in the US, Brazil and EU.

TriAltus Bioscience, a US-based protein purification technology spinout of University of Alabama at Birmingham (UAB), has raised $1.6m in a seed round featuring unnamed angel investors. Founded in 2017, TriAltus Bioscience is commercialising protein purification materials that utilise a technique called CL-4 affinity purification to quickly isolate proteins at a higher purity than alternative methods.…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.